Urinary apo(a) excretion is not altered by changes in glomerular filtration rate and renal plasma flow in healthy males

Wiener Klinische Wochenschrift

Volumn 112, Issue 3, 2000, Pages 121-125

  Kostner, Karam ^a   Clodi, Martin ^b   Bodlaj, Gert ^b   Hoffmann, Udo ^b   Hermann, Kathi ^b   Maurer, Gerald ^b   Pacher, Richard ^b   Hörl, Walter H ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Glomerular filtration rate; Lp(a); Renal plasma flow; Urinary apo(a) excretion

Indexed keywords

LIPOPROTEIN A; SOMATOSTATIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; KIDNEY PLASMA FLOW; MALE; NORMAL HUMAN; PROTEIN DEGRADATION; URINARY EXCRETION;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; APOLIPOPROTEINS A; GLOMERULAR FILTRATION RATE; HUMANS; INFUSIONS, INTRAVENOUS; LIPOPROTEIN(A); MALE; RENAL PLASMA FLOW; SEX FACTORS; SOMATOSTATIN;

EID: 0034635490     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Berg K, Dahlen G, Frick MH (1974) Lp(a) lipoprotein and pre-bl-lipoprotein in patients with coronary heart disease. Clin Genet 6: 230-235
2. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolobon G (1981) Lipoprotein Lp(a) and the risk for myocardial infarction Atherosclerosis 38: 51-61
3. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D (1986) The associated between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 62: 249-257
4. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyana M (1986) Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 59: 199-204
5. Cushing GL, Gaubatz JW, Nava ML, Burdick BJ, Bocan TMA, Guyton JR, Weilbaecher D, DeBakey ME, Lawrie GM, Morrisett JD (1989) Quantitation and localization of apolipoprotein(a) and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 9: 593-603
6. Maher VMG, Brown BG (1995) Lipoprotein(a) and coronary heart disease. Current Opinion Lipidol 6: 229-235
7. Krempler F, Kostner GM, Bolzano K, Sandhofer F (1979) Lipoprotein(a) is not a metabolic product of other lipoproteins containing apolipoproteinB. Biochim Biophys Acta 575: 63-70
8. Krempler F, Kostner GM, Bolzano K (1980) Turnover of lipoprotein(a) in man. J Clin Invest 65: 1483-1490
9. White AL, Lanford RE (1995) Biosynthesis and metabolism of lipoprotein(a). Current Opinion Lipodol 6: 75-80
10. Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL (1989) HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 80: 1313-1319
11. Kostner K, Maurer G, Huber K, Stefenelli T, Dieplinger H, Steyrer E, Kostner G (1996) Urinary excretion of apo(a) fragments: role in apo(a) catabolism. Atheroscl Thromb Vasc Biol 16/8: 905-911
12. Mooser V, Miguel CS, Moeen A, Landschulz K, Marcovina S, Hobbs HH (1996) Apolipoprotein(a) kringle 4-containing fragments in human urine. J Clin Invest 97: 858-864
13. Kostner K, Jansen M, Maurer G, Derfler K (1997) LDL-apheresis significantly reduces urinary apo(a) excretion. Eur J Clin Invest 27: 93-95
14. Vora J, Owens D, Luzio S, Atiea J, Ryder R, Hayes T (1987) Renal response to intravenous somatostatin in IDDM patients and normal subjects. Clin Endocrin Metab 64: 975-979
15. Tulassay T, Tulassay Z, Rascher W, Szücs L, Seyberth HW, Nagy I (1991) Effect of somatostatin on kidney function and vasoactive hormone systems in healthy subjects. Klin Wochenschr 69: 486-490
16. Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL (1989) HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 80: 1313-1319
17. Kronenberg F, Utermann G, Dieplinger H (1996) Lipoprotein (a) in renal disease. Am J Kidney Dis 27: 1-25
18. Kostner GM (1990) The physiological role of Lp(a). In: Scanu AM (ed) Lipoprotein (a). Academic Press, New York, pp 183-204
19. Mooser V, Marcovina S M, White A L, Hobbs H H (1996) Kringle containing fragments of apolipoprotein (a) circulate in human plasma and are excreted into the urine. J Clin Invest 98: 2414-2424
20. Edelstein C, Italia J A, Klezovitch, Scanu A M (1996) Functional and metabolic differences between elastase-generated fragments of human lipoprotein (a) apolipoprotein (a). J Lipid Res 37: 1786-1801
21. Kronenberg F, Trenkwalder E, Lingenhel A, Friedrich G, et al (1997) Renovascular arteriovenous differences in Lp(a) plasma concentrations suggest removal of Lp(a) from the renal circulation. J Lipid Res 38: 1755-1762